Testing effectiveness (Phase 2)Study completedNCT05995275
What this trial is testing
Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age
Who this might be right for
SmallpoxMpox
ModernaTX, Inc. 351